Page last updated: 2024-08-23

bromocriptine and pergolide

bromocriptine has been researched along with pergolide in 173 studies

Research

Studies (173)

Timeframe	Studies, this research(%)	All Research%
pre-1990	59 (34.10)	18.7374
1990's	56 (32.37)	18.2507
2000's	48 (27.75)	29.6817
2010's	6 (3.47)	24.3611
2020's	4 (2.31)	2.80

Authors

Authors	Studies
George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH	1
Anderson, PS; Baldwin, JJ; Clineschmidt, BV; Hirshfield, JM; Jones, JH; Lundell, GF; Martin, GE; McClure, DE; Randall, WC; Williams, M	1
Anderson, PS; Baldwin, JJ; Clineschmidt, BV; Hirshfield, JM; Jones, JH; Lumma, PK; Lundell, GF; Martin, GE; McClure, DE; Randall, WC; Remy, DC; Williams, M	1
Hamblin, MW; Jose, PA; Metcalf, MA; Monsma, FJ; Shen, Y; Sibley, DR	1
Dolak, LA; Duncan, JN; Heier, RF; Hyslop, DK; Lipton, MF; Martin, IJ; Mauragis, MA; Moon, MW; Nichols, NF; Piercey, MF; Schreur, PJ; Smith, MW	1
Brusniak, MY; DuRand, CJ; Huang, WH; Neve, KA; Pearlman, RS; Teeter, MM; Wiens, BL; Wilcox, DM; Wilcox, RE	1
Audinot, V; Boutin, JA; Cussac, D; Maiofiss, L; Millan, MJ; Newman-Tancredi, A	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Christoffersen, CT; Jensen, AA; Kehler, J; Krogsgaard-Larsen, N; Schrøder, TJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Oliveri, V	1
Diederich, NJ; Goetz, CG	1
Helton, DR; Modlin, DL; Williams, PD	1
Pawlikowski, M; Pisarek, H; Stepien, H	1
Berezin, M; Findler, G; Gutman, I; Horowitz, A; Tadmor, R	1
Colbert, W; Owen, N; Turk, J; Williams, P	1
Pisarek, H; Stepien, H	1
Ahlskog, JE; Carmichael, SW; Kelly, PJ; Nelson, A; Okazaki, H; Richelson, E; Stoddard, SL; Tyce, GM; van Heerden, JA	1
Kruk, ZL; Millar, J; Stamford, JA	1
Demichel, P; Moran, A; Roquebert, J; Sauvage, MF	1
Philosophe, R; Seibel, MM	1
Jacobs, MB; Varon, J	1
Ogawa, N	1
Davis, A; Jenner, P; Marsden, CD	1
Goetz, CG	1
Lamberts, SW; Quik, RF	1
Cooper, P; Donahue, B; Lee, C; Newall, J; Persky, M; Rush, S	1
Bemis, KG; Peters, SC; Shannon, HE	1
Avidan, D; Baron, E; Berezin, M	1
Alaoui, K; Morán, A; Roquebert, J	1
Rinne, UK	2
Arnold, WS; Touchet, N; Trugman, JM; Wooten, GF	1
Carroll, VS; Goetz, CG; Klawans, HL; Shannon, KM; Tanner, CM	1
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG	1
Jenner, P; Marsden, CD	1
Bernstein, J; Buckman, MT; Mattox, JH	1
Boyce, S; Jenner, P; Marsden, CD	1
Corenblum, B	1
Kletzky, OA; Shangold, GA	1
Borenstein, R; Kletzky, OA; Mileikowsky, GN	1
Libertun, C; Lux, VA; Ramírez, MI	1
D'Angelo, L; Fernández, M; Hawkins, M; Jantos, H; Monti, JM	1
Svensson, L	1
Althoff, PH; Fassbinder, W; Haak, T; Jungmann, E; Schöffling, K	1
Factor, SA; Sanchez-Ramos, JR; Weiner, WJ	1
Crosignani, PG; Ferrari, C	1
Klawans, HL; Paleologos, N	1
Ahmed, SR; Shalet, SM	1
Bernstein, J; Buckman, MT; Kellner, R; Mattox, JH; Pathak, D	1
Boyce, S; De Ceballos, ML; Jenner, P; Marsden, CD	1
Casey, DE	1
Jankovic, J	1
Goldstein, M; Lieberman, AN	1
Pepperell, RJ	1
Agid, Y; Dubois, B	1
Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD	1
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM	1
Adams, CB; Besser, GM; Charlesworth, M; Doniach, I; Grossman, A; Ross, R; Wass, JA	1
Mattox, JH	1
Burton, K; Calne, DB	1
Dhahir, P; Lemberger, L; Rubin, A	1
Butt, WR; Franks, S; Horrocks, PM; London, DR; Lynch, SS	1
Duvoisin, RC; Heikkila, RE; Manzino, L	1
Gianutsos, G; Palmeri, JL	1
Burke, JA; Chang, FW; Potter, DE	1
Arnerić, SP; Chow, SA; Fischer, LJ; Long, JP	1
Cook, DB; Hall, K; Johnston, DG; Kendall-Taylor, P; Patrick, D; Watson, M	1
Beckman, J; Burton, K; Calne, DB; Martin, WR	1
Blackwell, RE; Bradley, EL; Chang, RJ; DeVane, GW; Duvall, ER; Kline, LB; Vitek, JJ	1
Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD	1
Blackwell, RE; Bradley, EL; Rodgers-Neame, NT	1
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L	1
Login, IS	1
de Vries, JB; Feenstra, MG; Goedemoed, JH; Horn, AS; Rollema, H; Sumners, C	1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N	1
Noonan, JJ; Rose, DP	1
Ford, J; Jackson, JA; Jankovic, J	1
Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R	1
Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Toone, B	1
Fuller, RW; Perry, KW	1
Ahlenius, S; Engel, J; Larsson, K; Svensson, L	1
Johnels, B	1
Callaghan, JT; Crabtree, R; Lemberger, L	1
Besser, GM; Delitala, G; Grossman, A; Hathway, NR; Yeo, T	1
Agnati, LF; Andersson, K; Fuxe, K; Hökfelt, T; Köhler, C; Kuonen, D; Ogren, SO	1
Eadie, MJ	1
Bymaster, FP; Threlkeld, PG; Wong, DT	1
Angeleri, V; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G	1
Mark, MH; Sage, JI	1
Gsell, W; Lange, KW; Naumann, M; Oestreicher, E; Rausch, WD; Riederer, P	1
Angeleri, VA; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G	1
Blackard, WG	1
Comella, CL; Ristanovic, RK; Tanner, CM	1
Sarapura, V; Schlaff, WD	1
Clemens, JA; Okimura, T; Smalstig, EB	1
Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I	1
Angulo Cuesta, J; Guil Cid, M; Jiménez, FJ; López Alvarez, YJ; Sánchez-Chapado, M	1
Arai, N; Fukuyama, J; Isaji, M; Kuno, S; Miyata, H; Mizuta, E	1
Ahlskog, JE	1
Jin, GZ; Wei, YF; Zhang, XX	1
Canesi, M; Mariani, CB; Pesenti, A; Pezzoli, G	1
Asanuma, M; Gómez-Vargas, M; Kohno, M; Nishibayashi, S; Ogawa, N	1
Arai, N; Isaji, M; Itoh, F; Kojima, M; Miyagi, M; Taya, F; Ujiie, A	1
Kuno, S	1
Fici, GJ; Sethy, VH; VonVoigtlander, PF; Wu, H	1
Wienkers, LC; Wynalda, MA	1
Graham, JM; Grünewald, RA; Sagar, HJ	1
de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R	1
Müller, U; Pollmann, S; von Cramon, DY	1
Conner, P; Fried, G	1
Kuno, S; Mizuta, E; Yoshida, O; Yoshimura, N	1
Amano, K; Takakura, K	1
Allain, H; Bentué-Ferrer, D; Cardwell, GP; Hicks, CA; O'Neill, MJ; Reymann, JM; Ward, MA	1
Geyer, MA; Oostwegel, JL; Randolph, E; Swerdlow, NR; Taaid, N	1
Factor, SA	1
Weiner, WJ	1
Montastruc, JL; Rascol, O; Senard, JM	1
Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S	1
Antonini, A; Barichella, M; Canesi, M; Mariani, CB; Pezzoli, G; Tesei, S; Zecchinelli, AL	1
Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O	1
Clarke C, E; Speller J, M	1
Barbanoj, M; Casas, M; Jané, F; Prat, G; Robledo, P; Rubio, A	1
Brannan, T; Prikhojan, A; Yahr, MD	1
Sternon, J; Supiot, F; Zegers de Beyl, D	1
Jankovic, J; Le, WD	1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A	1
Fukui, T; Hira, K; Shimbo, T; Takemura, M	1
Hillman, R; Parvez, F; Pendleton, RG; Sayed, M	1
Auerbach, PP; Cadenhead, K; Eastvold, A; Geyer, MA; Karban, B; Ploum, Y; Stephany, N; Swerdlow, NR	1
Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R	1
Gekht, AB	1
Kuhlmann, A; Müller, T; Reimer, J	1
Bartholomeusz, CF; Box, G; Nathan, PJ; Van Rooy, C	1
Fujinami, A; Kuno, S; Matsui, H; Mizuta, I; Ohta, K; Ohta, M	1
Bankowski, BJ; Zacur, HA	1
Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P	1
Lang, AE; Razmy, A; Shapiro, CM	1
Araki, I; Kuno, S; Mizuta, E; Yamasaki, S	1
Hotta, M; Kamo, T; Kawakami, M; Nemoto, S; Oshima, J; Shimojo, S; Shiraishi, M; Sugihara, H; Takahashi, Y; Yasaki, S	1
Grosset, D; Grosset, K; Macphee, G; Needleman, F	1
Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP	1
Clarke, CE; Deane, KH; Spieker, S	1
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P	1
Hundemer, HP; Kolter, T; Roesch-Ely, D; Scheffel, H; Schwaninger, M; Weiland, S; Weisbrod, M	1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C	1
Abs, R; Verhelst, J	1
Molitch, ME	1
Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML	1
Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G	1
Chan, PL; Holford, NH; Kieburtz, K; Nutt, JG; Shoulson, I	1
Chung, EJ; Kim, JY; Lee, WY; Park, SW	1
Croft, RJ; Galloway, M; Guille, V; Leung, S; Nathan, PJ; O'Neill, BV; Phan, KL	1
Burger, E; Härtter, S; Kvernmo, T	1
Al-Fulaij, MA; Beinborn, M; Kopin, AS; Ren, Y	1
Hirohata, M; Ono, K; Yamada, M	1
Baldeweg, T; Croft, RJ; Leung, S; Nathan, PJ	1
Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K	1
Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C	1
Andersohn, F; Garbe, E	1
Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H	1
Pullan, PT	1
Alkabbani, A; Doshi, K; Hamrahian, A; Hatipoglu, B; Kennedy, L; Makin, V; Mon, SY; Olansky, L; Thorton, JN; Weil, R	1
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H	1
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ	1
Andrews, KD; Flashman, LA; Ford, JC; Kenny, RM; McAllister, TW; McDonald, BC; Saykin, AJ	1
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R	1
Kasica, N; Mackiewicz, J; Osęka, M; Saładziak, K; Święch, A	1
Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C	1

Reviews

38 review(s) available for bromocriptine and pergolide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation. European journal of medicinal chemistry, 2019, Apr-01, Volume: 167 Topics: alpha-Synuclein; Amyloidogenic Proteins; Drug Discovery; Humans; Protein Aggregation, Pathological; Structure-Activity Relationship	2019
Dopaminergic agonists in the treatment of Parkinson's disease. Neurologic clinics, 1992, Volume: 10, Issue:2 Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine	1992
Novel approaches to the management of hyperprolactinemia. Current opinion in obstetrics & gynecology, 1991, Volume: 3, Issue:3 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Hyperprolactinemia; Pergolide	1991
[New anti-parkinsonian drugs]. No to shinkei = Brain and nerve, 1991, Volume: 43, Issue:8 Topics: Antiparkinson Agents; Bromocriptine; Humans; Lisuride; Parkinson Disease; Pergolide; Picolinic Acids; Selegiline	1991
Dopaminergic agonists in the treatment of Parkinson's disease. Neurology, 1990, Volume: 40, Issue:10 Suppl 3 Topics: Bromocriptine; Dopamine Agents; Humans; Parkinson Disease; Pergolide	1990
Medical treatment of pituitary adenomas: effects on tumor growth. Journal of endocrinological investigation, 1985, Volume: 8, Issue:3 Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed	1985
Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology, 1987, Volume: 26, Issue:7B Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain; Bromocriptine; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Pergolide; Receptors, Dopamine; Trifluoperazine	1987
Receptor changes during chronic dopaminergic stimulation. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome	1988
Medical treatment of hyperprolactinaemic disorders. Human reproduction (Oxford, England), 1986, Volume: 1, Issue:8 Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen	1986
Long-term use of dopamine agonists in Parkinson's disease. Clinical neuropharmacology, 1985, Volume: 8, Issue:2 Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors	1985
Bromocriptine in Parkinson disease. Pharmacological reviews, 1985, Volume: 37, Issue:2 Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1985
The pharmacology of Parkinson's disease: basic aspects and recent advances. Experientia, 1984, Nov-15, Volume: 40, Issue:11 Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine	1984
Neuroprotection by dopamine agonists. Journal of neural transmission. Supplementum, 1994, Volume: 43 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Bromocriptine; Dopamine Agonists; Humans; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Pergolide	1994
Recent advances in the understanding of the pathophysiology and treatment of hyperprolactinemia. Current opinion in obstetrics & gynecology, 1993, Volume: 5, Issue:3 Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pergolide; Prolactin; Receptors, Dopamine D2; Signal Transduction; Treatment Outcome	1993
[Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease]. Archivos espanoles de urologia, 1995, Volume: 48, Issue:10 Topics: Aged; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Retroperitoneal Fibrosis	1995
Treatment of early Parkinson's disease: are complicated strategies justified? Mayo Clinic proceedings, 1996, Volume: 71, Issue:7 Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Selegiline	1996
Pergolide mesylate in Parkinson's disease treatment. Journal of neural transmission. Supplementum, 1995, Volume: 45 Topics: Antiparkinson Agents; Bromocriptine; Controlled Clinical Trials as Topic; Dopamine Agonists; Humans; Lisuride; Neuroprotective Agents; Pergolide	1995
[Treatment of Parkinson's disease with multiple drugs]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1 Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide	1997
Hyperprolactinemia; etiology, diagnosis and treatment alternatives. Acta obstetricia et gynecologica Scandinavica, 1998, Volume: 77, Issue:3 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pergolide; Prolactin; Receptors, Prolactin	1998
Dopamine agonists. The Medical clinics of North America, 1999, Volume: 83, Issue:2 Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome	1999
The initial treatment of Parkinson's disease should begin with levodopa. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors	1999
Treatment of Parkinson's disease should begin with a dopamine agonist. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles	1999
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide	2000
Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs & aging, 2001, Volume: 18, Issue:6 Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles	2001
Dopamine receptor agonists for treating prolactinomas. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:6 Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	2002
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4 Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone	2002
DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4 Topics: Bromocriptine; Dopamine Agonists; Ergot Alkaloids; Humans; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic	2002
[Use of dopamine agonists in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2002, Volume: 102, Issue:9 Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors	2002
Dopamine agonist therapy for hyperprolactinemia. Clinical obstetrics and gynecology, 2003, Volume: 46, Issue:2 Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles	2003
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4 Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone	2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone	2005
Hyperprolactinemia: pathophysiology and management. Treatments in endocrinology, 2003, Volume: 2, Issue:1 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative	2003
Pharmacologic resistance in prolactinoma patients. Pituitary, 2005, Volume: 8, Issue:1 Topics: Bromocriptine; Cabergoline; Cell Proliferation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Ergolines; Estrogens; Female; Humans; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2	2005
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clinical therapeutics, 2006, Volume: 28, Issue:8 Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine	2006
Anti-Parkinson's disease drugs and pharmacogenetic considerations. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7 Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline	2013
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms. Frontiers in endocrinology, 2021, Volume: 12 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2	2021
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis. European journal of pharmacology, 2023, Sep-05, Volume: 954 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole	2023

Trials

20 trial(s) available for bromocriptine and pergolide

Article	Year
A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia. The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:3 Topics: Adult; Amenorrhea; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Radiography	1991
Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia. American journal of obstetrics and gynecology, 1986, Volume: 154, Issue:2 Topics: Adult; Blood Pressure; Bromocriptine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Pergolide; Prolactin; Prospective Studies; Random Allocation; Time Factors	1986
Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy Arzneimittel-Forschung, 1988, Volume: 38, Issue:2 Topics: Adult; Aged; Aldosterone; Blood Pressure; Bromocriptine; Catecholamines; Dopamine; Female; Humans; Kidney; Male; Middle Aged; Norepinephrine; Pergolide; Pituitary Neoplasms; Prolactin; Renin; Stimulation, Chemical	1988
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide	1988
Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study. Fertility and sterility, 1983, Volume: 39, Issue:6 Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Dopamine; Ergolines; Female; Galactorrhea; Humans; Middle Aged; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Random Allocation	1983
Comparison of pergolide and bromocriptine therapy in parkinsonism. Neurology, 1983, Volume: 33, Issue:8 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1983
Pergolide in late-stage Parkinson disease. Annals of neurology, 1982, Volume: 12, Issue:3 Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders	1982
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. Neurology, 1995, Volume: 45, Issue:3 Suppl 3 Topics: Aged; Bromocriptine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1995
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4 Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide; Single-Blind Method; Treatment Outcome	1994
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1995
D1- versus D2-receptor modulation of visuospatial working memory in humans. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Apr-01, Volume: 18, Issue:7 Topics: Adult; Affect; Attention; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Memory, Short-Term; Pergolide; Photic Stimulation; Prefrontal Cortex; Prolactin; Psychomotor Performance; Receptors, Dopamine D1; Receptors, Dopamine D2; Space Perception	1998
Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist? Stereotactic and functional neurosurgery, 1997, Volume: 69, Issue:1-4 Pt 2 Topics: Aged; Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Stereotaxic Techniques; Treatment Outcome	1997
The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans. Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:1 Topics: Adolescent; Adult; Bromocriptine; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Pergolide; Psychomotor Performance; Receptors, Dopamine D1; Receptors, Dopamine D2	2003
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary, 2002, Volume: 5, Issue:4 Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin	2002
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:6 Topics: Aged; Antiparkinson Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Parkinson Disease; Pergolide; Prospective Studies; Treatment Outcome	2004
Differential dopaminergic modulation of executive control in healthy subjects. Psychopharmacology, 2005, Volume: 178, Issue:4 Topics: Adaptation, Psychological; Administration, Oral; Adult; Affect; Bromocriptine; Capsules; Cross-Over Studies; Domperidone; Double-Blind Method; Drug Administration Schedule; Feedback, Psychological; Functional Laterality; Hand; Humans; Male; Pergolide; Prefrontal Cortex; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Social Behavior	2005
Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology, 2006, Volume: 188, Issue:1 Topics: Acoustic Stimulation; Adult; Bromocriptine; Dopamine Agonists; Double-Blind Method; Evoked Potentials, Auditory; Humans; Male; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reference Values	2006
Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology, 2007, Volume: 194, Issue:4 Topics: Acoustic Stimulation; Administration, Oral; Adult; Analysis of Variance; Bromocriptine; Contingent Negative Variation; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Electroencephalography; Evoked Potentials; Evoked Potentials, Auditory; Humans; Male; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2	2007
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:6 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome	2009
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:3 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3	2013

Other Studies

115 other study(ies) available for bromocriptine and pergolide

Article	Year
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature, 1991, Apr-18, Volume: 350, Issue:6319 Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection	1991
Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists. Journal of medicinal chemistry, 1984, Volume: 27, Issue:12 Topics: Animals; Apomorphine; Cattle; Cerebral Cortex; Clonidine; Dopamine; Hydroxydopamines; Indicators and Reagents; Models, Molecular; Molecular Conformation; Motor Activity; Oxazines; Oxidopamine; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine; Rotation; Structure-Activity Relationship	1984
Synthesis of (7R)-7H-indolo[3,4-gh][1,4]benzoxazines, a new class of D-heteroergolines with dopamine agonist activity. Journal of medicinal chemistry, 1983, Volume: 26, Issue:3 Topics: Animals; Apomorphine; Cattle; Cerebral Cortex; Chemical Phenomena; Chemistry; Dopamine; Isomerism; Oxazines; Receptors, Adrenergic, alpha	1983
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. The Journal of biological chemistry, 1993, Aug-25, Volume: 268, Issue:24 Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Cell Line; Cell Membrane; Cloning, Molecular; Cyclic AMP; Gene Expression; Kidney Tubules, Proximal; Lysergic Acid Diethylamide; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Radioligand Assay; Rats; Receptors, Serotonin; Recombinant Proteins; Serotonin; Transfection	1993
Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolites. Journal of medicinal chemistry, 1997, Feb-28, Volume: 40, Issue:5 Topics: Aminoquinolines; Animals; Dopamine Agonists; Imidazoles; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Methylamines; Mice; Microsomes, Liver; Molecular Structure; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Serotonin Receptor Agonists; Stereoisomerism	1997
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors. Journal of medicinal chemistry, 2000, Aug-10, Volume: 43, Issue:16 Topics: Alanine; Amino Acid Substitution; Animals; Bromocriptine; Combinatorial Chemistry Techniques; Dopamine Agonists; Models, Molecular; Pergolide; Point Mutation; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Serine; Structure-Activity Relationship; Tumor Cells, Cultured	2000
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:2 Topics: Animals; Antiparkinson Agents; Binding Sites; Binding, Competitive; Cholinergic Antagonists; Cloning, Molecular; Cluster Analysis; Dopamine Agonists; Humans; Rats; Receptor, Muscarinic M1; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Serotonin	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Novel aza-analogous ergoline derived scaffolds as potent serotonin 5-HT₆ and dopamine D₂ receptor ligands. Journal of medicinal chemistry, 2014, Jul-10, Volume: 57, Issue:13 Topics: Ergolines; Humans; Ligands; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists	2014
Behavioral characterization of the new potent nonselective dopamine agonist pergolide. Arzneimittel-Forschung, 1992, Volume: 42, Issue:7 Topics: Analgesics; Animals; Avoidance Learning; Behavior, Animal; Body Temperature; Bromocriptine; Dogs; Female; Male; Mice; Motor Activity; Neuromuscular Junction; Oxotremorine; Pergolide; Postural Balance; Rats; Reserpine; Salivation; Seizures; Sleep; Time Factors	1992
Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary. Endocrine regulations, 1992, Volume: 26, Issue:1 Topics: Animals; Antiparkinson Agents; Bromocriptine; Diethylstilbestrol; Dose-Response Relationship, Drug; Ergolines; Female; Hyperplasia; Hyperprolactinemia; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Time Factors; Tritium	1992
Malignant prolactinoma. Acta endocrinologica, 1992, Volume: 127, Issue:5 Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Middle Aged; Orbital Neoplasms; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
General pharmacology of pergolide in animals. 1st communication: cardiovascular, respiratory and autonomic nervous system studies. Arzneimittel-Forschung, 1992, Volume: 42, Issue:5 Topics: Acetylcholine; Administration, Oral; Anesthesia; Animals; Autonomic Nervous System; Bromocriptine; Carotid Arteries; Decerebrate State; Dogs; Female; Guinea Pigs; Hemodynamics; In Vitro Techniques; Male; Muscle, Smooth; Norepinephrine; Pergolide; Rats; Rats, Inbred Strains; Respiration; Vagus Nerve	1992
The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats. Histology and histopathology, 1992, Volume: 7, Issue:1 Topics: Animals; Antiparkinson Agents; Bromocriptine; Cell Division; Diethylstilbestrol; Drug Interactions; Ergolines; Female; Hyperprolactinemia; Immunohistochemistry; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats	1992
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients. Annals of neurology, 1991, Volume: 30, Issue:2 Topics: Adult; Brain Tissue Transplantation; Bromocriptine; Caudate Nucleus; Down-Regulation; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Neurotransmitter; Spiperone	1991
Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data. British journal of pharmacology, 1991, Volume: 102, Issue:1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agents; Electrochemistry; Electrophysiology; Ergolines; In Vitro Techniques; Limbic System; Male; Microelectrodes; Nucleus Accumbens; Pergolide; Piperidines; Quinpirole; Rats; Rats, Inbred Strains; Stereotaxic Techniques	1991
Pharmacological characterization of dopamine receptors in parasympathetic innervation of rat heart. European journal of pharmacology, 1991, Jul-23, Volume: 200, Issue:1 Topics: Acetylcholine; Animals; Apomorphine; Bradycardia; Bromocriptine; Decerebrate State; Dopamine Agents; Electric Stimulation; Ergolines; Heart; Heart Rate; Male; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Vagus Nerve	1991
Treating the progressive stages of Parkinson's disease. Postgraduate medicine, 1991, Volume: 90, Issue:1 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline	1991
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour. Psychopharmacology, 1990, Volume: 100, Issue:1 Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride	1990
Prolactin reduction after combined therapy for prolactin macroadenomas. Neurosurgery, 1991, Volume: 28, Issue:4 Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Libido; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Retrospective Studies	1991
Effects of oral pergolide mesylate on nociceptive spinal cord reflexes in rats. Life sciences, 1991, Volume: 48, Issue:23 Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Female; Haloperidol; Pain; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reflex; Spinal Cord	1991
Long-term pergolide treatment of hyperprolactinemic patients previously unsuccessfully treated with dopaminergic drugs. Israel journal of medical sciences, 1991, Volume: 27, Issue:7 Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Lisuride; Magnetic Resonance Imaging; Male; Middle Aged; Pergolide; Prolactin; Tomography, X-Ray Computed	1991
Effect of bromocriptine on neurogenic vasoconstriction in the isolated autoperfused hindquarters of the rat. Fundamental & clinical pharmacology, 1990, Volume: 4, Issue:5 Topics: Animals; Apomorphine; Bromocriptine; Hindlimb; Male; Perfusion; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Vasoconstriction	1990
Early dopamine agonist therapy in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4 Suppl 1 Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine	1989
D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography. The Journal of pharmacology and experimental therapeutics, 1989, Volume: 250, Issue:3 Topics: Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Bromocriptine; Deoxyglucose; Glucose; Male; Oxazines; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Substantia Nigra	1989
Agonist substitution in advanced Parkinson's disease. Neurology, 1989, Volume: 39, Issue:8 Topics: Aged; Bromocriptine; Drug Evaluation; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1989
Control of hyperprolactinemia with pergolide. International journal of fertility, 1986, Volume: 30, Issue:4 Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin	1986
The medical treatment of the hypersecreting pituitary gland. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1985, Volume: 12, Issue:3 Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Valproic Acid	1985
Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle. American journal of obstetrics and gynecology, 1986, Volume: 154, Issue:2 Topics: Bromocriptine; Dopamine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Pergolide; Pituitary Gland, Anterior; Pituitary Hormone-Releasing Hormones; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone	1986
Dopamine agonists as primary treatment in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine	1987
Natural and artificially induced ovulatory models related to lactation in the rat: role of prolactin. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1988, Volume: 188, Issue:3 Topics: Animals; Bromocriptine; Female; Follicle Stimulating Hormone; Lactation; Luteinizing Hormone; Models, Biological; Ovulation; Ovulation Induction; Pergolide; Postpartum Period; Pregnancy; Prolactin; Rats; Rats, Inbred Strains	1988
Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology, 1988, Volume: 95, Issue:3 Topics: Animals; Apomorphine; Bromocriptine; Electroencephalography; Electromyography; Haloperidol; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sleep; Sleep, REM; Wakefulness	1988
Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat. Psychopharmacology, 1985, Volume: 85, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Bromocriptine; Ergolines; Lisuride; Male; Metergoline; Methiothepin; Naphthalenes; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Reflex, Startle; Tetrahydronaphthalenes	1985
International symposium on early dopamine agonist therapy of Parkinson's disease. Archives of neurology, 1988, Volume: 45, Issue:2 Topics: Animals; Bromocriptine; Carbidopa; Dopamine; Humans; Levodopa; Parkinson Disease; Pergolide; Time Factors	1988
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. Clinical neuropharmacology, 1986, Volume: 9, Issue:3 Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis	1986
Discordant responses of prolactinoma to two different dopamine agonists. Clinical endocrinology, 1986, Volume: 24, Issue:4 Topics: Adult; Bromocriptine; Drug Resistance; Ergolines; Female; Humans; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed	1986
Dopamine agonists for reducing depression associated with hyperprolactinemia. The Journal of reproductive medicine, 1986, Volume: 31, Issue:8 Topics: Analysis of Variance; Bromocriptine; Depression; Depressive Disorder; Drug Evaluation; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin	1986
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats. European journal of pharmacology, 1986, Nov-04, Volume: 130, Issue:3 Topics: Animals; Basal Ganglia; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neurotensin; Pergolide; Rats; Rats, Inbred Strains; Trifluoperazine	1986
Behavioral effects of long-term neuroleptic treatment in Cebus monkeys. Psychopharmacology. Supplementum, 1985, Volume: 2 Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cebus; Dextroamphetamine; Dopamine; Ergolines; Haloperidol; Humans; Mastication; Pergolide; Receptors, Dopamine; Stereotyped Behavior	1985
Management of prolactinomas. A reappraisal. The Australian & New Zealand journal of obstetrics & gynaecology, 1985, Volume: 25, Issue:3 Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors	1985
[Dopaminergic agonists in Parkinson disease]. La Revue du praticien, 1986, Jan-21, Volume: 36, Issue:5 Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil	1986
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases. Cancer, 1985, Feb-01, Volume: 55, Issue:3 Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin	1985
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology, 1985, Volume: 35, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors	1985
The effect of dopamine agonist therapy on large functionless pituitary tumours. Clinical endocrinology, 1985, Volume: 22, Issue:5 Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prospective Studies	1985
Dopamine agonists in hyperprolactinemia. Fertility and sterility, 1985, Volume: 44, Issue:4 Topics: Bromocriptine; Ergolines; Humans; Hyperprolactinemia; Pergolide	1985
Dopamine agonists and Parkinson's disease. Clinical neurology and neurosurgery, 1984, Volume: 86, Issue:3 Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine	1984
Physiologic disposition of pergolide. Clinical pharmacology and therapeutics, 1981, Volume: 30, Issue:2 Topics: Adult; Animals; Bromocriptine; Chromatography, High Pressure Liquid; Ergolines; Feces; Humans; Male; Middle Aged; Pergolide	1981
Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment. Lancet (London, England), 1981, Sep-26, Volume: 2, Issue:8248 Topics: Administration, Oral; Adult; Bromocriptine; Depression, Chemical; Ergolines; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Pergolide; Prolactin; Time Factors	1981
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway. Neurology, 1982, Volume: 32, Issue:12 Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains	1982
Effects of three dopamine agonists on cage climbing behavior. Psychopharmacology, 1983, Volume: 79, Issue:4 Topics: Animals; Behavior, Animal; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Motor Activity; Pergolide	1983
Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment. Current eye research, 1984, Volume: 3, Issue:2 Topics: Administration, Topical; Animals; Bromocriptine; Domperidone; Ergolines; Eye; Ganglia, Sympathetic; Intraocular Pressure; Male; Pergolide; Rabbits; Sympathectomy	1984
Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas. The Journal of pharmacology and experimental therapeutics, 1984, Volume: 228, Issue:3 Topics: Adrenal Medulla; Animals; Apomorphine; Blood Glucose; Bromocriptine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Ergolines; Indans; Insulin; Islets of Langerhans; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydronaphthalenes	1984
Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography. Lancet (London, England), 1984, Jul-28, Volume: 2, Issue:8396 Topics: Adult; Aged; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica; Tomography, X-Ray Computed	1984
Dopamine agonists in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2	1984
Long-term monolayer culture of human anterior pituitary cells: functional validation of a method. Fertility and sterility, 1984, Volume: 41, Issue:1 Topics: Bromocriptine; Cells, Cultured; Ergolines; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Methods; Pergolide; Pituitary Gland, Anterior; Prolactin; Thyrotropin-Releasing Hormone; Time Factors	1984
Pergolide versus bromocriptine. Neurology, 1984, Volume: 34, Issue:2 Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pergolide	1984
A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity. Naunyn-Schmiedeberg's archives of pharmacology, 1983, Volume: 324, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Behavior, Animal; Bromocriptine; Dopamine; Ergolines; Homovanillic Acid; Models, Neurological; Motor Activity; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine	1983
Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea. Cancer research, 1982, Volume: 42, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromocriptine; Ergolines; Female; Growth Hormone; Hypophysectomy; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Nitrosourea Compounds; Pergolide; Prolactin; Rats	1982
Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Annals of neurology, 1983, Volume: 13, Issue:3 Topics: Aged; Bromocriptine; Bulbar Palsy, Progressive; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide	1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease. Advances in neurology, 1983, Volume: 37 Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1983
Dopa dose-dependent sexual deviation. The British journal of psychiatry : the journal of mental science, 1983, Volume: 142 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Pergolide	1983
Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats. Biochemical pharmacology, 1982, Jun-15, Volume: 31, Issue:12 Topics: 4-Butyrolactone; Animals; Brain Chemistry; Bromocriptine; Dopamine; Ergolines; Furans; Haloperidol; Pergolide; Rats; Rats, Inbred Strains	1982
Effects of pergolide and bromocriptine on male rat sexual behavior. Journal of neural transmission, 1982, Volume: 54, Issue:3-4 Topics: Animals; Bromocriptine; Ergolines; Male; Pergolide; Rats; Sexual Behavior, Animal	1982
Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens. Pharmacology, biochemistry, and behavior, 1982, Volume: 17, Issue:2 Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Corpus Striatum; Ergolines; Locomotion; Male; Motor Activity; Nucleus Accumbens; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei	1982
Pergolide, a potent long-acting dopamine-receptor agonist. Clinical pharmacology and therapeutics, 1980, Volume: 27, Issue:5 Topics: Adult; Blood Pressure; Bromocriptine; Circadian Rhythm; Dose-Response Relationship, Drug; Ergolines; Ergot Alkaloids; Growth Hormone; Hormones; Humans; Male; Middle Aged; Myocardial Contraction; Pergolide; Perphenazine; Prolactin; Receptors, Dopamine; Time Factors	1980
Two new dopamine agonists that are long acting in vivo but short acting in vitro. Clinical endocrinology, 1980, Volume: 13, Issue:6 Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; In Vitro Techniques; Male; Pergolide; Prolactin; Rats; Secretory Rate; Time Factors	1980
Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides. Journal of neural transmission, 1981, Volume: 51, Issue:1-2 Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Corpus Striatum; Ergolines; Kinetics; Organ Specificity; Pergolide; Putamen; Rats; Receptors, Dopamine	1981
Treatment of Parkinson's disease. Australian family physician, 1995, Volume: 24, Issue:9 Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Pergolide; Prognosis; Selegiline	1995
Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites. Arzneimittel-Forschung, 1993, Volume: 43, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Binding, Competitive; Brain Chemistry; Bromocriptine; Cattle; Corpus Striatum; Dopamine; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; In Vitro Techniques; Membranes; Pergolide; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2	1993
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile. Annals of neurology, 1995, Volume: 37, Issue:1 Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating	1995
Edema--an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs. The American journal of medicine, 1993, Volume: 94, Issue:4 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Edema; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma	1993
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Annals of neurology, 1993, Volume: 34, Issue:5 Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM	1993
Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior. Arzneimittel-Forschung, 1993, Volume: 43, Issue:3 Topics: Administration, Oral; Animals; Bromocriptine; Corpus Striatum; Injections, Intraperitoneal; Male; Oxidopamine; Pergolide; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reserpine; Stereotyped Behavior; Substantia Nigra	1993
Differential effects of three dopamine receptor agonists in MPTP-treated monkeys. Journal of neural transmission. Parkinson's disease and dementia section, 1995, Volume: 10, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Macaca fascicularis; Parkinson Disease, Secondary; Pergolide	1995
Agonistic actions of pergolide on firing activity of dopamine neurons in substantia nigra compacta area. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1995, Volume: 16, Issue:5 Topics: Animals; Bromocriptine; Dopamine Agonists; Electrophysiology; Male; Neurons; Pergolide; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra	1995
Scavenging effects of dopamine agonists on nitric oxide radicals. Journal of neurochemistry, 1996, Volume: 67, Issue:5 Topics: Benzoates; Bromocriptine; Dopamine Agonists; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Imidazoles; Kinetics; Nitric Oxide; Pergolide; Spin Labels	1996
Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats. Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:9 Topics: Animals; Benzazepines; Binding, Competitive; Bromocriptine; Cabergoline; Dopamine Agonists; Dopamine Antagonists; Ergolines; In Vitro Techniques; Male; Pergolide; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior	1996
D1 dopamine receptor activity of anti-parkinsonian drugs. Life sciences, 1997, Volume: 60, Issue:18 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Benzothiazoles; Bromocriptine; Cells, Cultured; Cerebellum; Clozapine; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiazoles	1997
Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen. Drug metabolism and disposition: the biological fate of chemicals, 1997, Volume: 25, Issue:10 Topics: Benzothiazoles; Bromocriptine; Cytochrome P-450 Enzyme Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Pergolide; Pramipexole; Thiazoles	1997
Hallucinosis in idiopathic Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:4 Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors	1997
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease]. Revista de neurologia, 1997, Volume: 25, Issue:145 Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor	1997
Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:1 Topics: Animals; Bromocriptine; Dopamine Agonists; Ergolines; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex; Triazoles; Urinary Bladder; Urination	1998
Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. European journal of pharmacology, 1998, Jul-03, Volume: 352, Issue:1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Brain Ischemia; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Gerbillinae; Haloperidol; Hippocampus; Lisuride; Neuroprotective Agents; Pergolide; Receptors, Dopamine D2	1998
Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behavioural pharmacology, 1998, Volume: 9, Issue:5-6 Topics: Acoustic Stimulation; Amantadine; Animals; Bromocriptine; Dopamine Agents; Dopamine Agonists; Drug Interactions; Humans; Indoles; Male; Pergolide; Rats; Rats, Sprague-Dawley; Reflex, Startle; Species Specificity	1998
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data. Journal of the neurological sciences, 1999, Nov-30, Volume: 170, Issue:2 Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors	1999
An overnight switch to ropinirole therapy in patients with Parkinson's disease. Short communication. Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:9-10 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Therapeutic Equivalency	1999
Sleep attacks and Parkinson's disease treatment. Lancet (London, England), 2000, Apr-15, Volume: 355, Issue:9212 Topics: Accidents, Traffic; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Piribedil	2000
Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats. Brain research, 2000, Jun-23, Volume: 868, Issue:2 Topics: Animals; Bromocriptine; Caffeine; Denervation; Drug Administration Schedule; Drug Combinations; Drug Tolerance; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Rats; Rats, Sprague-Dawley; Rotation	2000
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:10 Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles	2000
[Dopaminergic agonists in the treatment of Parkinson's disease]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6 Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles	2000
Pergolide and Parkinson's disease: new preparation. No clear benefit. Prescrire international, 2000, Volume: 9, Issue:50 Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome	2000
Efficacy and tolerability of dopamine agonists in a parkinsonian population. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome	2001
Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan. PharmacoEconomics, 2001, Volume: 19, Issue:8 Topics: Aged; Bromocriptine; Cost-Benefit Analysis; Dopamine Agonists; Female; Hospitalization; Humans; Japan; Male; Markov Chains; Middle Aged; Parkinson Disease; Pergolide; Quality-Adjusted Life Years	2001
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins	2002
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology, 2002, Volume: 161, Issue:2 Topics: Adolescent; Adult; Amantadine; Amphetamine; Analysis of Variance; Blood Pressure; Bromocriptine; Dopamine Agonists; Double-Blind Method; Heart Rate; Humans; Male; Pergolide; Psychomotor Performance; Reflex, Startle; Time Factors	2002
Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide. Parkinsonism & related disorders, 2002, Volume: 9, Issue:2 Topics: Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Pergolide	2002
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life sciences, 2003, Jun-20, Volume: 73, Issue:5 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Astrocytes; Blotting, Northern; Brain-Derived Neurotrophic Factor; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Ergolines; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred ICR; Nerve Growth Factor; Nerve Growth Factors; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors	2003
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Archives of neurology, 2004, Volume: 61, Issue:1 Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness	2004
Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients. Parkinsonism & related disorders, 2004, Volume: 10, Issue:3 Topics: Aged; Bromocriptine; Female; Humans; Middle Aged; Parkinson Disease; Patient Selection; Pergolide; Urination Disorders	2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles	2004
Cardiopulmonary complications of ergot-derivative dopamine agonists. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10 Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone	2004
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12 Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2004
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary, 2005, Volume: 8, Issue:1 Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome	2005
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement. Parkinsonism & related disorders, 2006, Volume: 12, Issue:5 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Bromocriptine; Disability Evaluation; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pergolide; Prognosis; Survival Analysis	2006
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments. Journal of pharmacokinetics and pharmacodynamics, 2006, Volume: 33, Issue:3 Topics: Algorithms; Antiparkinson Agents; Bayes Theorem; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Models, Biological; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Selegiline; Treatment Outcome	2006
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Dopamine Agonists; Echocardiography; Ergot Alkaloids; Heart Valve Diseases; Humans; Middle Aged; Parkinson Disease; Pergolide; Reference Values	2006
Identification of amino acid determinants of dopamine 2 receptor synthetic agonist function. The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:1 Topics: Amino Acid Sequence; Amino Acid Substitution; Amino Acids; Animals; Binding Sites; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Drosophila; Humans; Indoles; Ligands; Luciferases; Molecular Sequence Data; Mutation; Pergolide; Piribedil; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Transfection	2007
Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro. Journal of neuroscience research, 2007, May-15, Volume: 85, Issue:7 Topics: alpha-Synuclein; Antiparkinson Agents; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; In Vitro Techniques; Molecular Structure; Neurofibrillary Tangles; Pergolide; Polymers; Selegiline; Trihexyphenidyl	2007
The frequency of cardiac valvular regurgitation in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7 Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence	2008
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:2 Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors	2009
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1 Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States	2009
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy. Internal medicine journal, 2009, Volume: 39, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography	2009
Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas. Pituitary, 2013, Volume: 16, Issue:4 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Thromboembolism; Young Adult	2013
Differential Effects of Pergolide and Bromocriptine on Working Memory Performance and Brain Activation after Mild Traumatic Brain Injury. Journal of neurotrauma, 2021, 01-15, Volume: 38, Issue:2 Topics: Adolescent; Adult; Brain; Brain Concussion; Bromocriptine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Pergolide; Young Adult	2021
The Inhibitory Effect of Selected D Cells, 2022, 04-02, Volume: 11, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Bromocriptine; Cabergoline; Dopamine Agonists; Hypoxia; Larva; Neovascularization, Pathologic; Pergolide; Vascular Endothelial Growth Factor A; Zebrafish	2022

chemdatabank.com